Aclaris Therapeutics, Inc. ACRS
5.15
(0.23)
(4.28%)
as of 25 Sep
- Market cap
- $589.0M
- P/E
- 0.0×
Follow ACRS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 37.28 | 18.51 | 42.46 | 122.00 | 33.03 | 2.35 | 10.24 | 47.14 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (38.63) | (10.51) | (3.84) | (31.07) | (48.31) | (51.41) | (10.84) | (21.45) | (28.10) |
P/B ratio |
— | 3.12 | 1.33 | 1.12 | 7.31 | 4.18 | 4.97 | 0.47 | 1.23 | 3.58 |
Price to Tangible BV |
— | 3.53 | 1.51 | 1.25 | 9.02 | 4.33 | 5.15 | 0.47 | 1.23 | 3.59 |
EV/Sales |
— | 0.00 | 19.31 | 1.61 | 35.75 | 94.02 | 25.77 | (1.41) | 4.27 | 35.78 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.46 | 0.00 | 0.00 |
EV/Operating CF |
— | (9.32) | (1.47) | (0.07) | (6.00) | (12.19) | (11.35) | 0.56 | (3.98) | (5.94) |
EV/FCF |
— | (9.12) | (1.45) | (0.07) | (5.93) | (12.12) | (11.25) | 0.55 | (3.96) | (5.93) |
Quick Ratio |
22.05 | 15.23 | 6.16 | 3.38 | 3.69 | 8.37 | 9.94 | 3.86 | 3.99 | 3.36 |
Current Ratio |
22.27 | 15.69 | 6.57 | 3.74 | 3.87 | 8.94 | 10.55 | 4.16 | 3.99 | 3.36 |
Net Debt/EBITDA |
2.83 | 3.59 | 1.67 | 0.83 | 0.88 | 2.13 | 2.43 | 1.23 | 0.80 | 1.20 |
Debt/Assets |
0.00% | 0.00% | 10.86% | 3.63% | 15.05% | 0.88% | 0.62% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.14 | 0.05 | 0.28 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.01 | 0.02 | 0.02 | 0.08 | 0.04 | 0.12 | 0.14 | 0.09 | 0.04 |
Operating CF/Net income |
0.72 | 0.80 | 0.76 | 0.60 | 0.76 | 0.57 | 0.78 | 0.89 | 0.15 | 0.73 |
Capex/Depreciation |
(1.93) | (3.07) | (0.72) | (0.06) | (0.34) | (0.33) | (0.76) | (1.52) | (44.52) | (0.24) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (36.70%) | (34.72%) | (60.28%) | (113.22%) | (94.86%) | (77.34%) | (44.01%) | (49.88%) | (84.46%) | (50.20%) | |
| (35.59%) | (32.66%) | (51.14%) | (86.32%) | (60.34%) | (56.44%) | (34.36%) | (39.15%) | (63.23%) | (34.10%) | |
ROIC |
(94.07%) | (108.19%) | (68.76%) | 0.00% | 0.00% | (689.92%) | 0.00% | (159.82%) | (211.41%) | (387.11%) |
Return on Tangible Assets |
(36.20%) | (36.14%) | (85.95%) | (252.74%) | (115.23%) | (49.53%) | (41.25%) | (88.90%) | (138.49%) | (94.87%) |
Average Days of Receivables |
— | 104.32 | 33.41 | 60.79 | 43.47 | 33.63 | 5.94 | 3.48 | 240.94 | 259.55 |
Research and Development Expense of Revenue |
0.00% | 2,127.39% | 989.12% | 1,517.98% | 452.61% | 648.03% | 261.54% | 314.84% | 179.41% | 672.69% |
Selling, General and Administrative Expense of Revenue |
0.00% | 1,130.90% | 418.81% | 658.32% | 316.72% | 349.34% | 84.47% | 103.72% | 118.61% | 280.76% |
Intangible Assets out of Total Assets |
0.00 | 0.11 | 0.09 | 0.07 | 0.10 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 857.40% | 326.04% | 382.71% | 172.89% | 207.96% | 50.55% | 65.74% | 57.99% | 158.24% |
Graham Net Nets |
— | 0.26 | 0.42 | 0.71 | 0.09 | 0.18 | 0.18 | 1.21 | 0.32 | 0.11 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (9.63%) | (54.67%) | (206.88%) | (18.55%) | (11.21%) | (8.83%) | (120.95%) | (60.89%) | (17.61%) |
Free Cash Flow Yield |
— | (7.95%) | (35.67%) | (125.30%) | (14.20%) | (6.36%) | (6.94%) | (108.64%) | (10.54%) | (12.80%) |
Revenue per Share |
0.00 | 0.06 | 0.19 | 0.10 | 0.15 | 0.12 | 0.46 | 0.45 | 0.24 | 0.06 |
Operating CF per Share |
(1.62) | (1.95) | (3.06) | (2.33) | (0.91) | (0.92) | (1.04) | (1.12) | (0.26) | (0.38) |
Capex per Share |
(0.01) | (0.04) | (0.04) | (0.04) | (0.01) | (0.01) | (0.01) | (0.02) | (0.46) | 0.00 |
Free Cash Flow per Share |
(1.63) | (1.99) | (3.10) | (2.37) | (0.92) | (0.92) | (1.05) | (1.14) | (0.72) | (0.39) |
Cash per Share |
6.41 | 6.90 | 5.10 | 1.82 | 1.27 | 3.37 | 3.34 | 1.71 | 1.47 | 0.74 |
Shareholders Equity per Share |
7.91 | 8.02 | 6.54 | 1.69 | 0.89 | 3.48 | 3.03 | 2.25 | 2.01 | 0.84 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.91 | 8.02 | 6.54 | 1.69 | 0.89 | 3.48 | 3.03 | 2.25 | 2.01 | 0.84 |
Free Cash Flow |
(34.83) | (55.90) | (102.17) | (98.06) | (39.09) | (52.44) | (68.17) | (79.63) | (56.01) | (47.22) |
Working Capital |
132.33 | 187.46 | 152.16 | 61.37 | 42.62 | 182.10 | 209.61 | 97.90 | 94.36 | 67.67 |
Capital Expenditures |
(0.23) | (1.23) | (1.36) | (1.61) | (0.45) | (0.31) | (0.60) | (1.31) | (35.93) | (0.11) |
Net Current Asset Value |
131.96 | 181.97 | 119.06 | 55.42 | 24.36 | 151.16 | 174.58 | 88.63 | 61.18 | 38.94 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.73 | 0.22 | 0.38 | 0.07 | 0.05 | 0.02 | 0.04 | 1.92 | 0.01 |
Net Profit Margin |
0.00% | (4,071.48%) | (2,157.99%) | (3,817.22%) | (787.03%) | (1,343.96%) | (292.11%) | (283.15%) | (705.48%) | (829.58%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.25 | 0.19 | 0.82 | 10.09 | 0.80 | 0.69 | 0.73 | 0.53 | 0.80 | 0.60 |
Cash ROIC |
(11.44%) | (13.56%) | (24.96%) | (66.61%) | (39.33%) | (13.68%) | (16.48%) | (28.94%) | (7.83%) | (24.70%) |
Accounts Receivable Turnover |
— | 3.22 | 11.78 | 6.67 | 8.78 | 9.69 | 53.75 | 79.92 | 2.96 | 0.87 |
Accounts Payable Turnover |
0.07 | 0.23 | 0.44 | 0.38 | 0.68 | 0.62 | 1.18 | 1.88 | 2.28 | 0.82 |
Inventory Turnover |
0.00 | 0.00 | 12.25 | 11.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
8,653.54 | 2,365.39 | 984.38 | 892.65 | 373.60 | 773.29 | 315.90 | 179.22 | 110.74 | 659.35 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.52 | 0.52 | 0.63 | 0.74 | 0.70 | 0.55 | 0.39 | 6.33 | 8.96 |
Average Payables |
1.83 | 5.33 | 9.75 | 10.80 | 7.59 | 7.62 | 10.17 | 9.61 | 6.78 | 8.92 |
Average Inventory |
— | — | 0.35 | 0.35 | — | — | — | — | — | — |
Average Assets |
135.08 | 209.80 | 259.54 | 186.93 | 84.54 | 161.00 | 252.90 | 226.00 | 208.87 | 190.39 |
Average Common Equity |
131.01 | 197.38 | 220.19 | 142.52 | 53.78 | 117.50 | 197.48 | 177.40 | 156.37 | 129.32 |
Columns are period end dates